Relatively little is known of the growth requirements for regenerating axons of the peripheral nervous system of adult animals. In the present study, we show that extracellular matrix material secreted by the Engelbreth-Holm-Swarm tumor cell line (matrigel) supports axonal growth from explanted peripheral nerve-dorsal root ganglia (DRG) preparations of adult mice and amphibia in serum-free media, without addition of growth factors. Axonal growth in matrigel was much more profuse than that in the more commonly used gels of type 1 collagen and, after some days in culture, was accompanied by migration of Schwann cells along axons. The most abundant protein in matrigel is laminin, which has been shown in many studies to support axonal growth but, surprisingly, antisera to laminin did not inhibit axonal growth in matrigel. To determine the ability of the major components of matrigel, laminin, type IV collagen, and heparan sulfate proteoglycan (HSPG), to support axonal growth, these proteins were added to preparations of mouse peripheral nerve-DRGs in type I collagen gels. Regenerating axons were significantly longer in the presence of laminin and type IV collagen than in control cultures, while HSPG had a slight inhibitory effect. In this assay system, however, diluted matrigel solution was even more effective in stimulating axonal growth than laminin or type IV collagen, either alone or in combination. The results suggest that in addition to laminin and type IV collagen, other components within matrigel may contribute to its ability to support axonal growth. r 1997 Academic Press
INTRODUCTION
Neurons of the peripheral nervous systems of embryonic and neonatal mammals and birds have been widely used in studies of axonal growth in vitro, but relatively few investigations have been carried out on neurons of adult animals. The growth requirements for neurons from adult animals are therefore uncertain and may differ from those of neurons of immature animals. For example, myelin-associated glycoprotein (MAG) stimulates neurite outgrowth from neurons of neonatal animals but inhibits growth from adult animals (31) . Neonatal dorsal root ganglion (DRG) neurons extend neurites on frozen sections of both normal and degenerating nerves but neurite extension from adult neurons occurs only on sections of degenerating nerves (2) . The neurite outgrowth from adult neurons in this situation might both be promoted by the lack of MAG and also due to stimulation by factors produced within the lesioned nerves. Proteins expressed during Wallerian degeneration, which have been shown to stimulate neurite outgrowth in vitro, include nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF) (30) the cell adhesion molecules NCAM and L1 (see review, 29) , and the extracellular matrix (ECM) molecule laminin (8) .
Neurite outgrowth occurs in cultures of dissociated DRG neurons of adult rats on laminin (26) and its initial onset is enhanced by addition of NGF or BDNF. Neurite outgrowth also occurs from explanted ganglia of the peripheral nervous system of embryonic and neonatal animals in response to addition of NGF but this may decline with age (9) . In gels of type 1 collagen, axonal outgrowth has been observed from the cut ends of peripheral nerve-dorsal root preparations of adult mice (17) , although the mean numbers of axons per preparation (typically 9-10 for 3-month-old mice) were small.
Recent experiments in our laboratories have shown that vigorous regeneration of sensory axons of adult mice and amphibia occurs after nerve crush in vitro (14, 43, 10, 11) , indicating that axonal growth of adult animals can occur in culture, given suitable conditions. In the present investigations, the growth of axons from peripheral nerves of adult mammals and amphibia in matrigel, a commercially available extract of ECM, secreted by the Engelbreth-Holm-Swarm (EHS) tumor cell line (20) , was studied in vitro. Axonal growth was consistently better in matrigel than in type 1 collagen and did not require addition of serum or growth factors. In further experiments, the activity of the major protein components in matrigel was investigated by adding them to preparations in type I collagen and studying their effects on axonal growth. A prelimi-nary account of some of these findings has already been presented in abstract form (44) .
MATERIALS AND METHODS

Mouse Preparations
Adult mice aged 5-8 weeks (NMR-1 and BK1 TO strains, obtained from Bomholtgaard, Denmark, and B & K Universal Ltd., UK, respectively) were anesthetised by either CO 2 or ether and killed by cervical dislocation. From each animal, up to 16 preparations consisting of short lengths of thoracic and lumbar segmental nerves with their attached DRG were removed by dissection. The preparations were placed on 13-mm glass coverslips in 35-mm petri dishes and covered with 20-30 µl of matrigel or ''growth factorreduced'' (GFR) matrigel (Becton-Dickinson Labware), part of which was removed with a pipette to leave a thin film of fluid. The dishes were then placed in a humidified incubator for about 15 min in order for the matrigel to solidify, after which the preparations were covered with 2 ml of RPMI 1640 medium containing 100 units of penicillin, 100 µg streptomycin, and 250 ng amphotericin B per milliliter (obtained from Sigma) and subsequently maintained at 36°C in an atmosphere containing 95% air/5% CO 2 . The preparations were kept in a sealed box containing 95% O 2 /5% CO 2 within a humidified incubator at 36°C, under which conditions the numbers of axons growing out of the explants appeared to be enhanced.
In separate experiments the preparations were explanted into thin gels of (type 1) collagen (Sigma) which were prepared as described (34, 42) . In some experiments, pairs of peripheral nerve preparations were cultured in multiwells with 500 µl of RPMI medium which contained laminin or GFR matrigel in solution or without addition in control experiments. In other experiments, 10% of the type I collagen was substituted with type IV collagen or a solution of 1 mg/ml heparan sulfate proteoglycan (HSPG) from EHS tumors (Sigma). The concentrations of type IV collagen and HSPG in these gels were 301 and 70 µg/ml, respectively, which were higher than the estimated concentrations in diluted GFR matrigel (55 and 9 µg/ml) but lower than those in set matrigel (3.7 mg/ml and 600 µg/ml).
Amphibian Preparations
In experiments using amphibia, DRGs and segmental nerves from adult axolotls (Ambystoma mexicanum) purchased from Tachbrook Tropicals (U.K.) and frogs (Rana temporaria and Rana pipiens) obtained from the Frog Farm (Kells, Ireland) and from Blades (UK) were explanted into matrigel. The animals were anesthetised by immersion in a solution of tricaine methane sulfonate (approximately 0.1% w/v) and killed by destruction of the brain, after which their spinal nerves with attached DRGs were removed by dissection. Explants of these nerves in matrigel were maintained at 21°C in RPMI 1640 medium, diluted to approximately 225 mOsm/kg H 2 O. The medium was changed once per week.
Immunocytology
The primary antibodies used in this study were rabbit polyclonal antibody to protein gene product 9.5 kDa (PGP 9.5), purchased from Ultraclone Ltd., and mouse monoclonal antibodies to neurofilament 200 (Sigma, clone NE 14) and RT97 (a gift from B. Anderton). A rabbit polyclonal antibody (48) to the lowaffinity NGF receptor (p75) was a gift from L. Reichardt. Tetramethyl rhodamine isothiocyanate (TRITC)-, fluorescein isothiocyanate (FITC)-, and horseradish peroxidase (HRP)-conjugated secondary antibodies were from Sigma. The concentrations of the antibodies used were 1:100 except for a-PGP 9.5 (1:200), a-p75 (1:1000), and RT97 (1:25).
Preparations were fixed by immersion in 3.6% (w/v) formaldehyde in phosphate buffer (PB) for approximately 1 h. The preparations were then blocked with 3% (w/v) bovine serum albumin (BSA) and 0.1% (w/v) Triton X-100 in phosphate-buffered saline (PBS) for a further hour. Primary antibodies were added in 3% BSA in PBS and left on the preparations overnight. The preparations were then washed with five changes of PBS during the following day and secondary antibodies added (in 3% BSA) overnight. After a further five washes in PBS during the next day, the preparations were mounted in Citifluor (City University, UK) and viewed using a fluorescence microscope.
In experiments where HRP-conjugated secondary antibodies were used, after the final series of washes the preparations were incubated in 0.6 mg/ml diaminobenzidine (DAB) in Tris-buffered saline (TBS), pH 7.6, for 10 min and then 1 µl/ml of 30% H 2 O 2 was added to visualize peroxidase activity. In some experiments 30 µl of 1% CoCl 2 (w/v) was included with the DAB solution to intensify the reaction product. After staining, the preparations were mounted in glycergel (Dako) and viewed using a Zeiss Standard microscope with an image projection tube.
Assessment of Axonal Growth
Axonal outgrowth was assessed in living preparations using an inverted phase-contrast microscope with an attached video camera and video graphic printer. In preparations in collagen gels which had been fixed and stained using HRP-conjugated secondary antibody, the lengths of axons growing out of the cut ends of peripheral nerves (usually 10-20 per preparation) were determined from camera lucida drawings using a Bit Pad 2 digitizer tablet (Summagraphics), a PC, and Digit Image Analysis Software (B. P. Hayes Software). In control preparations it was usually possible to draw all axons. However, in preparations incubated with medium containing laminin or matrigel, axon numbers were much greater and so drawings were made of a representative selection of axons which could be traced along their whole lengths from explant to growth cone. Where axon branching occurred, only the longest branch was drawn.
Experiments Involving Antibodies to Laminin
Three antisera, raised against mouse EHS laminin at King's College, were used in these experiments. Two antisera were raised in rabbits by Dr. S. Kemplay, while the third was raised by ourselves in a guinea pig. All three antibodies recognized EHS laminin on Western blots and bands corresponding to laminin A and B chains in matrigel (data not shown). To determine whether the antisera could block the ability of laminin to support neurite outgrowth in a standard assay system, DRGs from E9 chick embryos (Needle Farm, Enfield, UK) were explanted onto coverslips which had been coated with 50 µl of a solution of 25 ng/ml laminin (Sigma) and incubated in DMEM medium containing 10 ng/ml 7.5S NGF (Sigma) and 10% of either antiserum to laminin or control serum from normal rabbit or guinea pig.
Statistical Analysis
Results are expressed as means 6 SEM. The differences between means were evaluated by a Student's t test where appropriate and considered significant at P , 0.05.
RESULTS
Axonal Outgrowth
When preparations of mouse peripheral nerves with their attached DRGs were explanted into matrigel, fine axons grew out of the cut ends of the peripheral nerve stump and dorsal roots within 1 day and continued elongating for several days. The best growth was observed from intercostal nerve-DRG preparations, which were used for most experiments. Measurements taken after 3 days showed that the longest axons had extended 700-800 µm from the explants, indicating that axons may grow at rates of 200-300 µm per day. An example of the profuse axonal outgrowth seen after a few days in culture is shown in Fig. 1A , using a-PGP 9.5 which recognizes all mammalian neurons and their processes (49) .
In some experiments, explants of DRGs were trimmed to remove the peripheral nerves and spinal roots but axonal growth from these preparations was shorter than when the nerves were left attached to the ganglia (data not shown).
Preparations of amphibian thoracic and lumbar nerves also showed axonal outgrowth within 1 day of culture and remained viable for up to 2 weeks. Axonal numbers growing out of amphibian nerves in culture appeared to be at least as great as those in the mouse but axonal elongation was slower. To determine axonal growth rates in the frog, seven axons in four separate nerve preparations were inspected during a period of up to 20 days and photomicrographs made. Outgrowth distance was determined by direct measurement on the micrographs. After an initial delay of 1-2 days, there was a period of 8 days with vigorous axonal outgrowth (0.5-6 µm/h) followed by a period of 8 days with declining growth rates (Fig. 2) . Signs of degeneration were visible after 16 days and by 20 days most axons had fragmented. Axonal growth from axolotl preparations taken from different animals was quite variable but in many cases, axons had extended 300-400 µm from the explants after 3 days, indicating growth rates of about 100 µm per day.
Amphibian preparations were stained using antibodies which have been characterized in mammals. In frog nerve preparations, axons were labeled by mAb NE14 (Fig. 3A) , which recognizes the 200-kDa neurofilament subunit in mammals (7) . In axolotl nerve preparations, many of the thicker axons were labeled by mAb RT97 (Fig. 3B ), which recognizes a phosphorylation epitope on the 200-kDa neurofilament subunit and in mammals is a selective marker for large-diameter myelinated axons (24) . Staining with this antibody was reduced in intensity or absent toward the tips of the axons, which could be explained by the delayed occurrence of neurofilament phosphorylation during axonal growth (33) .
Axonal Growth in GFR-Matrigel and in Collagen
According to the manufacturer's specifications, ordinary matrigel contains (as a proportion of protein by weight) 56% laminin, 31% type IV collagen, 8% entactin, 5% HSPG, and small amounts of growth factors including epidermal growth factor (EGF), plateletderived growth factor (PDGF), insulin-like growth factor-1 (IGF-1), and transforming growth factor-b (TGF b ). GFR matrigel has similar concentrations of the heavymolecular-weight ECM components to ordinary matrigel but the levels of low-molecular-weight proteins including growth factors are reduced (41) . Axonal growth in preparations of both mouse and amphibian nerves in this form of matrigel appeared to be as vigorous as those in ordinary matrigel. Most experiments with mouse nerve preparations were carried out using GFR matrigel.
Preparations of mouse nerves in collagen gels also showed axonal outgrowth within the first day in culture, but the numbers of axons were always fewer than those in GFR matrigel (see Fig. 1C ). The mean number of axons growing out of the cut end of peripheral nerve preparations in type 1 collagen after 3 days (19.7 6 3.1; n 5 6) was significantly less (P , 0.001) than the numbers counted in GFR matrigel (68.8 6 4.7; n 5 6). The total numbers of axons growing in GRF matrigel were probably considerably higher than the numbers actually counted since axonal outgrowth close to the cut nerve stump was dense and so short axons terminating within this zone would probably have been missed.
Preparations of amphibian nerves were also cultured in type 1 collagen but very little axonal outgrowth was seen from frog nerves and even less from those of axolotls.
Cellular Migration
In preparations of mouse and amphibian peripheral nerves axons always grew alone at first, but after a few days some cells began to migrate from the explants. In some cases cells appeared to migrate along the axons and in mouse peripheral nerve preparations could be labeled by a-p75 (Figs. 4A and 4B) and were therefore presumably Schwann cells, which are known to express p75 in lesioned nerves (18) . In the same preparations, other cells which had a flattened appearance and were usually not attached to axons were unlabeled by a-p75 (Figs. 4C and 4D) and were therefore presumably fibroblasts.
Effects of Antibodies to Laminin on Axonal Growth
Since axonal growth in matrigel was much more profuse than in type I collagen, it seemed of interest to determine the component(s) in matrigel which supported axonal growth. Laminin is the most abundant protein in matrigel and is very effective in supporting   FIG. 2 . The outgrowth of seven individual sensory axons from four preparations of frog peripheral nerves in matrigel observed during a period of 20 days. The outgrowth distances from the nerve endings were determined from photomicrographs taken using an inverted phase-contrast microscope at intervals of 1, 2, or 3 days. neurite outgrowth (22) . It might therefore be expected that antibodies to laminin would inhibit axonal growth within matrigel. In preliminary experiments, all three antisera, when tested at a dilution of 1:10 in RPM1 medium, blocked neurite outgrowth from E9 chick DRGs on EHS laminin (Fig. 5B ) but in similar preparations, this concentration of serum from a normal rabbit and a normal guinea pig did not inhibit neurite outgrowth (Fig. 5A) . In two experiments, mouse peripheral nerve-DRG preparations were incubated in GFR matrigel in microwells with medium containing 10% either laminin antisera or serum from a normal rabbit or guinea pig. However, examination of these cultures using a phase-contrast microscope showed that axonal outgrowth after 3 days in the presence of antisera to laminin was similar to that with control serum (Figs.  5C and 5D ). At the end of the experiment nerve preparations were removed from the matrigel and bound a-laminin was demonstrated using HRP-conjugated a-rabbit, indicating that the antibodies to laminin had been able to diffuse into the gels. The failure of the antisera to inhibit axonal outgrowth seems unlikely to be due to use of insufficient antibodies since their titer in the media at the end of the experiment was $1/40,000, as determined by enzyme-linked immunoassay.
Although the antisera to laminin failed to inhibit axonal growth, this result does not necessarily exclude laminin as a factor in supporting axonal growth observed in matrigel. In other studies, antibodies to laminin also failed to inhibit axonal growth stimulated by conditioned media (28, 12, 4, 23, 6) , although the neurite-outgrowth-stimulating factor(s) in the media could be immunoprecipitated or immunosequestered by antisera to laminin (4, 23, 6) . The explanation for this phenomenon is uncertain but could be due to steric hindrance of antibody binding by other proteins complexed to laminin (23) .
ECM Components May Stimulate Axonal Growth in Collagen Gels
In order to determine which proteins in matrigel are able to support axonal growth, individual ECM components were added to type I collagen gels to see if they would stimulate axonal growth. In preliminary experiments, laminin (100 µg/ml) or GFR matrigel, diluted to an equivalent protein concentration, was added to the collagen gels before setting and found to cause variable, but significant increases in axonal length (data not shown). More consistent results were obtained when 100 µg/ml laminin or GFR matrigel, diluted to provide the same laminin concentration, was added to the medium in which the preparations were incubated, as summarized in Table 1 . In control preparations cultured for 3 days in collagen, only limited axonal outgrowth was observed (Fig. 6A) . Axons growing from preparations in the presence of laminin (Fig. 6B) or GFR matrigel (Fig. 6C) were significantly longer (P , 0.001) than those from control preparations. Axonal lengths were significantly longer (P , 0.001) in the presence of GFR matrigel than laminin. Furthermore, the numbers of axons growing out of the explants in the presence of laminin or GFR matrigel seemed to be enhanced, although the dense tangled outgrowth of fine axons, particularly in the presence of GFR matrigel, made this difficult to quantify.
In experiments in which the gels contained 10% type IV collagen, axons were also significantly longer (P , 0.001) than those in control preparations (Table 1) but not as long as those in diluted GFR matrigel, and the numbers of axons appeared to be less than in the presence of laminin or GFR matrigel. Addition of HSPG to the collagen gels resulted in a small but significant decrease (P , 0.05) in axonal length (Table 1) .
In a further experiment, laminin (100 µg/ml) was added to preparations in type I collagen with or without 10% type IV collagen but mean axonal lengths (302 6 14 µm, n 5 74, and 305 6 20 µm, n 5 66, respectively) were not significantly different and the presence of both proteins together did not seem to increase the numbers of regenerating axons. This result indicates that under the conditions of the experiment, type IV collagen and laminin do not produce additive effects on axonal growth.
DISCUSSION
Knowledge of factors influencing growth of peripheral nerve axons of adult mammals has been limited because, unlike the situation in developing animals, neurites do not readily grow out of explanted ganglia into gels of substances such as collagen. Neurite outgrowth from DRG explants of adult amphibia has been observed only after prolonged periods in culture (35) . Isolated neurons from dissociated DRGs of adult rats extend neurites on laminin (26) but in these experiments the normal relationship between neurons and FIG. 5. Phase-contrast photomicrographs of axonal growth from E9 chick DRGs on laminin in the presence of 10 ng/ml NGF (A and B) after 1 day and mouse intercostal nerves in matrigel (C and D) after 3 days. In media containing 10% serum from a normal rabbit, profuse axonal outgrowth occurs from both the explanted chick ganglion (A) and mouse nerve (C). In media containing 10% rabbit antiserum to laminin, the axons from the chick DRG detach from the coverslip but fasciculate with each other, forming cables which link the ganglia together (B). In contrast, the antiserum to laminin appears to have no effect on axonal growth from the mouse intercostal nerve (D). In C and D, arrowheads show the terminations of some of the longest axons visible within the fiels of view of each preparation. Note that not all axons are within the plane of focus. Bar, 200 µm (A, C, and D), 500 µm (B). (17) have demonstrated that limited axonal outgrowth occurs from the cut ends of peripheral nerve-DRG preparations of adult mice in gels of type 1 collagen, as was observed in the present investigations. However, in our experiments these gels did not support axonal growth from ganglia of amphibia. In contrast, peripheral nerve axons of both amphibia and mice regenerated promptly when explanted into matrigel, suggesting that the growthpromoting substance(s) which it contains (and their corresponding receptors on axonal growth cones) have been conserved during evolution.
Matrigel is a complex mixture of proteins, including high-molecular-weight substances such as laminin, HSPG, collagen type IV, and nidogen (20) . More recently, it has also been shown to contain low-molecularweight growth factors such as PDGF, IGF-1, EGF, and TGF b (47) . Of these substances, laminin, HSPG, and type IV collagen have been shown to support neurite outgrowth (16, 25, 21) and IGF-1 has been shown to stimulate axonal regeneration in vivo (40, 32) . However, the fact that GFR matrigel was at least as effective as ordinary matrigel in supporting axonal outgrowth suggests that the lower molecular weight proteins, including the growth factors, are of minor importance for axonal growth in matrigel.
The most abundant protein in matrigel is laminin, which is known to be an effective substrate for axonal growth (22) and might therefore be expected to be of importance in supporting axonal growth in matrigel. However, the three antisera to laminin used in the present investigations did not inhibit axonal growth within matrigel, although they all inhibited neurite outgrowth of chick sensory neurons on coverslips coated with laminin. Addition of laminin to collagen gels enhanced axonal growth, however, indicating that axons are in fact responsive to laminin. The reason for the failure of antisera to laminin to block axonal growth in matrigel and neurite outgrowth in conditioned media containing laminin (28, 12, 4, 23, 6 ) is uncertain. It has been suggested (13) that the neurite-outgrowth-promoting domain of laminin is not normally antigenic, but can be sterically hindered by antibodies binding to the globular tail of the long arm of the laminin molecule. HSPGs can bind to this globular region of the laminin molecule and might in turn prevent antibodies binding to this domain (23) , although whether the HSPG content of matrigel would be sufficient to mask all these epitopes on laminin is uncertain. It is also possible that complexes formed between the ECM components of matrigel cause conformational changes to laminin so that it is no longer recognized by antibodies to purified laminin. Laminin-HSPG complexes create a new epitope (5) which is recognized by the INO antibody which FIG. 6. Examples of axonal outgrowth from mouse intercostal nerves after 3 days in collagen, visualized using a-PGP 9.5 and HRP-conjugated secondary antibody and photographed using darkfield illumination. In a control preparation (A) only a few short axons grow out of the nerve explant. In contrast, both the numbers of growing axons and their lengths are increased in preparations cultured in the presence of 100 µg/ml laminin (B) or matrigel solution diluted to contain the same laminin concentration (C). Arrows show the terminations of the longest axons visible within the field of view of each preparation. Note that not all axons are within the plane of focus. Bar, 200 µm. also recognizes basal laminae in peripheral nerve and muscle and inhibits axonal regeneration in vivo (38) .
An alternative explanation for the failure of antibodies to laminin to inhibit axonal growth in matrigel is that other components within it are also capable of supporting regeneration. Since type IV collagen and HSPG have been shown to stimulate axonal outgrowth from embryonic neurons (16, 25, 21) it seemed of interest to add them to preparations of adult peripheral nerves in gels of type I collagen to determine their effects on axonal growth. The results of these experiments indicate that axonal lengths are increased by type IV collagen but not by HSPG. However, on the basis of its content of laminin and type IV collagen, diluted GFR matrigel was more effective in stimulating axonal growth than either of these proteins when tested individually but there was no summation of stimulatory effects when these two proteins were added together. The absence of summation could be explained by the fact that both laminin and type IV collagen might activate common receptors (45, 37) or signaling pathways. The greater effectiveness of diluted GFR matrigel compared with laminin and type IV collagen in stimulating axonal growth might be due to conformational changes or stabilization resulting from formation of complexes between different ECM components in matrigel. Entactin has been shown to mediate the formation of complexes between laminin, type IV collagen, and HSPG (1) but since it may be necessary to produce it in recombinant form for it to be fully active (1), investigation into its possible role in promoting axonal growth was not attempted in the present study.
The ability matrigel to support axonal growth in vitro is of interest in its own right since it has also been shown to enhance peripheral nerve regeneration in vivo (27) and suggests that laminin-containing preparations of human ECM might also facilitate axonal regeneration. The subunit chains of laminin have been sequenced and cloned (46) but biological activity of the recombinant proteins has yet to be demonstrated (36) . However, synthetic peptides homologous to amino acids occurring on A and B2 laminin chains attached to agarose and collagen have been reported to promote axonal growth in vitro and in vivo, respectively (3, 19) . Our findings suggest, however, that the ability of laminin to support axonal growth may be enhanced by association with other ECM components. Since ECM extracts containing laminin and other proteins have been prepared from human amnions (39) and a human tumor cell line (15) it would be interesting to determine whether they are capable of stimulating axonal growth. Mouse peripheral nerve-DRG preparations, as used in the present study, provide a rapid and economical method for screening the ability of ECM components and also neurotrophic factors to stimulate axonal growth (42) .
